HomeREVB • NASDAQ
add
Revelation Biosciences Inc
Previous close
$2.00
Day range
$1.90 - $2.01
Year range
$1.90 - $60.48
Market cap
3.26M USD
Avg Volume
580.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.46M | -2.42% |
Net income | -2.44M | 70.86% |
Net profit margin | — | — |
Earnings per share | -7.01 | 97.15% |
EBITDA | -2.45M | 2.43% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.17M | -57.15% |
Total assets | 5.40M | -56.03% |
Total liabilities | 1.57M | -85.90% |
Total equity | 3.83M | — |
Shares outstanding | 1.70M | — |
Price to book | 0.80 | — |
Return on assets | -131.40% | — |
Return on capital | -183.49% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.44M | 70.86% |
Cash from operations | -1.92M | 22.57% |
Cash from investing | — | — |
Cash from financing | 3.39M | — |
Net change in cash | 1.47M | 159.28% |
Free cash flow | -1.01M | -123.51% |
About
Founded
2019
Website
Employees
8
